Dupilumab Ups Histologic Response for Pediatric Eosinophilic Esophagitis; Significant improvements seen in histologic, endoscopic, and transcriptomic measures in higher-exposure dupilumab regimen.

Press/Media

Period27 Jun 2024

Media coverage

1

Media coverage

  • TitleDupilumab Ups Histologic Response for Pediatric Eosinophilic Esophagitis; Significant improvements seen in histologic, endoscopic, and transcriptomic measures in higher-exposure dupilumab regimen.
    Media name/outletPhysician's Briefings
    Country/TerritoryUnited States
    Date27/06/24
    PersonsMirna Chehade